SURAJ MODI: Open Payments
NPI 1144756305 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 26 payments from 17 companies in 2025. Trend: 2023 $455 · 2024 $1,033 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Exact Sciences Corporation | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Noven Therapeutics, LLC | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
Products named: INGREZZA, Cologuard Collection Kit, REXULTI, Kerendia, MOUNJARO, OTEZLA, Xelstrym, ZENPEP.
Industry payments across FL — which companies pay providers there.
